84 related articles for article (PubMed ID: 16103466)
21. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
[TBL] [Abstract][Full Text] [Related]
22. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
[TBL] [Abstract][Full Text] [Related]
23. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
24. HIV Infection and Survival of Lymphoma Patients in the Era of Highly Active Antiretroviral Therapy.
Han X; Jemal A; Hulland E; Simard EP; Nastoupil L; Ward E; Flowers CR
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):303-311. PubMed ID: 27756777
[No Abstract] [Full Text] [Related]
25. Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma.
Montoto S; Wilson J; Shaw K; Heath M; Wilson A; McNamara C; Orkin C; Nelson M; Johnson M; Bower M; Cwynarski K
AIDS; 2010 Mar; 24(6):851-6. PubMed ID: 20124971
[TBL] [Abstract][Full Text] [Related]
26. Non-Hodgkin's lymphoma as a rare manifestation of immune reconstitution disease in HIV-1 positive patients.
Knysz B; Kuliszkiewicz-Janus M; Jeleń M; Podlasin R; Gładysz A
Postepy Hig Med Dosw (Online); 2006; 60():547-51. PubMed ID: 17060896
[TBL] [Abstract][Full Text] [Related]
27. HIV-associated non-Hodgkin's lymphoma: experience from a regional cancer center.
Sharma A; Bajpai J; Raina V; Mohanti BK
Indian J Cancer; 2010; 47(1):35-9. PubMed ID: 20071788
[TBL] [Abstract][Full Text] [Related]
28. Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study.
Hoffmann C; Hentrich M; Gillor D; Behrens G; Jensen B; Stoehr A; Esser S; van Lunzen J; Krznaric I; Müller M; Oette M; Hensel M; Thoden J; Fätkenheuer G; Wyen C
HIV Med; 2015 Apr; 16(4):261-4. PubMed ID: 25252101
[TBL] [Abstract][Full Text] [Related]
29. Reduced incidence of Kaposi's sarcoma and of systemic non-hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy.
Carrieri MP; Pradier C; Piselli P; Piche M; Rosenthal E; Heudier P; Durant J; Serraino D
Int J Cancer; 2003 Jan; 103(1):142-4. PubMed ID: 12455069
[No Abstract] [Full Text] [Related]
30. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
[TBL] [Abstract][Full Text] [Related]
31. Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphoma.
Stebbing J; Gazzard B; Mandalia S; Teague A; Waterston A; Marvin V; Nelson M; Bower M
J Clin Oncol; 2004 Jun; 22(11):2177-83. PubMed ID: 15169806
[TBL] [Abstract][Full Text] [Related]
32. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
[TBL] [Abstract][Full Text] [Related]
33. Immune recovery following antineoplastic chemotherapy and highly active antiretroviral therapy (HAART) in a child with HIV-1 infection previously unresponsive to HAART.
Galli L; Chiappini E; Lippi A; de Martino M
Int J Immunopathol Pharmacol; 2006; 19(4):919-22. PubMed ID: 17166413
[TBL] [Abstract][Full Text] [Related]
34. Encouraging news on lymphoma from France.
TreatmentUpdate; 2001 Oct; 13(6):3-4. PubMed ID: 11768868
[No Abstract] [Full Text] [Related]
35. [Resistance avoided, prognosis improved--myocet in AIDS-related non-Hodgkin's lymphoma].
Pohlmann BK
Onkologie; 2004 Oct; 27(5):514-5. PubMed ID: 15595188
[No Abstract] [Full Text] [Related]
36. AIDS-associated gastrointestinal lymphoma: is there a role for surgery in the standard of care?
Fasan ML; Morandi E; Fociani P; Benatti SV; Mainini A; Ridolfo AL; Pastecchia C; Cargnel A
J Acquir Immune Defic Syndr; 2003 Nov; 34(3):345-7. PubMed ID: 14600583
[No Abstract] [Full Text] [Related]
37. Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).
Chow KU; Mitrou PS; Geduldig K; Helm EB; Hoelzer D; Brodt HR
Leuk Lymphoma; 2001 Mar; 41(1-2):105-16. PubMed ID: 11342362
[TBL] [Abstract][Full Text] [Related]
38. AIDS related systemic non-Hodgkin's lymphoma.
Powles T; Matthews G; Bower M
Sex Transm Infect; 2000 Oct; 76(5):335-41. PubMed ID: 11141847
[TBL] [Abstract][Full Text] [Related]
39. Markers of microbial translocation and risk of AIDS-related lymphoma.
Marks MA; Rabkin CS; Engels EA; Busch E; Kopp W; Rager H; Goedert JJ; Chaturvedi AK
AIDS; 2013 Jan; 27(3):469-74. PubMed ID: 23169327
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.
Lim ST; Karim R; Tulpule A; Nathwani BN; Levine AM
J Clin Oncol; 2005 Nov; 23(33):8477-82. PubMed ID: 16230675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]